We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Aerometrex Limited is a software-application business based in Australia. Aerometrex shares (AMX) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Aerometrex has a trailing 12-month revenue of around $21.1 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $0.63 - $1.44 |
|---|---|
| 50-day moving average | $0.7617 |
| 200-day moving average | $0.805 |
| Target price | $1.31 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.044 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.755
| 1 week (2021-10-12) | 4.86% |
|---|---|
| 1 month (2021-09-17) | -4.43% |
| 3 months (2021-07-19) | -6.79% |
| 6 months (2021-04-19) | -17.03% |
| 1 year (2020-10-19) | -42.80% |
|---|
Valuing Aerometrex stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aerometrex's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Aerometrex's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.7 million (£0.0 million).
The EBITDA is a measure of a Aerometrex's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $21.1 million |
|---|---|
| Gross profit TTM | $7.4 million |
| Return on assets TTM | -5.48% |
| Return on equity TTM | -11.29% |
| Profit margin | -19.56% |
| Book value | 0.364 |
| Market capitalisation | $68.9 million |
TTM: trailing 12 months
We're not expecting Aerometrex to pay a dividend over the next 12 months.
Aerometrex's shares were split on 21 January 2009.
Aerometrex Limited, a geospatial tech company, provides aerial photography, photogrammetry, light detection and ranging (LiDAR) surveys, 3D modelling, and aerial imagery subscription services in Australia and the United States. The company offers aerial photography and mapping, including aerial photographs, orthophotography, digital terrain models, digital surface models, and digitized 3D feature data for geographic information systems; and aerial LiDAR surveys, such as aerometrex that provides an aerial LiDAR surveying service, an aerial surveying technique, which maps the ground surface using airborne lasers. It also provides 3D solutions, which include 3D modelling and mapping system derived from oblique aerial photographs; and MetroMap, an online imagery web-serving application. The company serves architecture, engineering, and construction; energy and utilities; environment and disaster management; events, media, and entertainment; forestry and agriculture; government; insurance and financial services; natural resources, mining, and exploration; property and real estate; telecommunications; and transport, logistics, and traffic management industries. Aerometrex Limited was founded in 1980 and is headquartered in Glynde, Australia.
Shares in the trans-Tasman dairy company are down 55% over the last 12 months.
Shares in the Brisbane-based lender have risen nearly 60% in the last 12 months.
The 10 biggest movers on the ASX for Wednesday 13 October 2021.
Everything we know about the Tissue Repair IPO, plus information on how to buy in.
This guide will show you step-by-step instructions on how to buy the Illuvium (ILV) token as well as a list of exchanges you can trade it on.
Westpac shares are up 43% over the past 12 months.
Airports, travel agents and pubs are set to soar post lockdown, but should share investors look beyond immediate short-term wins?
Shares in the insurer are up just 10% in the last 12 months.
Everything we know about the Nimy Resources IPO, plus information on how to buy in.
